Draft Guidance for IRBs, Clinical Investigators, and Sponsors: IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE Is Needed
The Food and Drug Administration made available a draft guidance entitled "Guidance for IRBs, Clinical Investigators and Sponsors: IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites and the Determination of Whether an IND/IDE Is Needed"
Action
Published Date
Agency
Contact Information
Doreen Kezer, 301-796-8524
Department
More Information
Pages
69631-69632
Program Area
Volume Number
77